Your provider will discuss the benefits and considerations of extended use during regular check-ins
It suggests theres an additive effect of these two medications, said Andrew Saxon, an addiction psychiatrist at the University of Washington who was not involved with this study, potentially because liraglutide and buprenorphine target different mechanisms
Retatrutide should not be presented as an approved weight loss medication, a guaranteed fat-loss treatment, or a replacement for nutrition, exercise, behavioral support, or medical care
A sub-study of this trial focused on GC through the use of continuous glucose monitoring (CGM) and the proportion of time within a tight predefined time in range (TIR) from 71 to 140 mg/dL at the end of the study was considerably more significant in the group of participants receiving either 10 or 15 mg TZP competed to the group taking insulin degludec (72, 73, 75)
Keep your healthcare provider informed about every change
medRxiv [Internet]